176 related articles for article (PubMed ID: 32184655)
1. OTUD4: A Potential Prognosis Biomarker for Multiple Human Cancers.
Zhao X; Su X; Cao L; Xie T; Chen Q; Li J; Xu R; Jiang C
Cancer Manag Res; 2020; 12():1503-1512. PubMed ID: 32184655
[TBL] [Abstract][Full Text] [Related]
2. OTU deubiquitinase 4 is silenced and radiosensitizes non-small cell lung cancer cells via inhibiting DNA repair.
Wu Z; Qiu M; Guo Y; Zhao J; Liu Z; Wang H; Meng M; Yuan Z; Mi Z
Cancer Cell Int; 2019; 19():99. PubMed ID: 31011293
[TBL] [Abstract][Full Text] [Related]
3. The prognostic gene CRABP2 affects drug sensitivity by regulating docetaxel-induced apoptosis in breast invasive carcinoma: A pan-cancer analysis.
Zeng S; Xu Z; Liang Q; Thakur A; Liu Y; Zhou S; Yan Y
Chem Biol Interact; 2023 Mar; 373():110372. PubMed ID: 36736488
[TBL] [Abstract][Full Text] [Related]
4. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
Zhu HZ; Zhou WJ; Wan YF; Ge K; Lu J; Jia CK
World J Gastroenterol; 2020 Feb; 26(8):804-817. PubMed ID: 32148378
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic-Mediated Downregulation of Zinc Finger Protein 671 (
Zhang J; Zheng Z; Zheng J; Xie T; Tian Y; Li R; Wang B; Lin J; Xu A; Huang X; Yuan Y
Front Oncol; 2019; 9():342. PubMed ID: 31134149
[TBL] [Abstract][Full Text] [Related]
8. Identification of
Zheng R; Zhu HL; Hu BR; Ruan XJ; Cai HJ
World J Clin Cases; 2020 Jul; 8(14):2917-2929. PubMed ID: 32775374
[TBL] [Abstract][Full Text] [Related]
9. Investigation on the Potential Correlation Between
Yao L; Zhong X; Huang G; Ma Q; Xu L; Xiao H; Guo X
Front Cell Dev Biol; 2021; 9():730337. PubMed ID: 34778250
[No Abstract] [Full Text] [Related]
10. Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells.
Li Z; Tian Y; Zong H; Wang X; Li D; Keranmu A; Xin S; Ye B; Bai R; Chen W; Yang G; Ye L; Wang S
Apoptosis; 2024 Mar; ():. PubMed ID: 38553613
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinating enzyme OTUD4 regulates metastasis in triple-negative breast cancer by stabilizing Snail1.
Ma X; Wan R; Wen Y; Liu T; Song Y; Zhu Y
Exp Cell Res; 2024 Jan; 434(1):113864. PubMed ID: 38040050
[TBL] [Abstract][Full Text] [Related]
12. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
Jin CY; Du L; Nuerlan AH; Wang XL; Yang YW; Guo R
Aging (Albany NY); 2020 Dec; 13(3):3518-3535. PubMed ID: 33411689
[TBL] [Abstract][Full Text] [Related]
13. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
14. Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma.
Lin Z; Xie YZ; Zhao MC; Hou PP; Tang J; Chen GL
Cancer Cell Int; 2021 Sep; 21(1):475. PubMed ID: 34496841
[TBL] [Abstract][Full Text] [Related]
15. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
16. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic or prognostic values of FADD in cancers based on pan‑cancer analysis.
Wang C; Jiang X; Zhao Q; Xie Z; Cai H
Biomed Rep; 2023 Nov; 19(5):77. PubMed ID: 37829257
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
19. DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer.
Deng Z; Xiao M; Du D; Luo N; Liu D; Liu T; Lian D; Peng J
Onco Targets Ther; 2021; 14():2003-2017. PubMed ID: 33776450
[TBL] [Abstract][Full Text] [Related]
20. Pancancer Analysis of the Oncogenic and Prognostic Role of
Liu Q; Xie R; Li Y
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
